Stilbene compounds as PPAR beta / delta inhibitors for the treatment of PPAR beta / delta-mediated diseases

摘要

The present invention relates to substances which act as selective ligands of PPAR beta / delta subtype nuclear receptors and can be used for the treatment of PPAR beta / delta-mediated diseases. The substances according to the invention act as inhibitors of the PPAR beta / delta receptor.